Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Test Case Selection in Pre-Deployment Testing of Complex Clinical Decision Support Systems.

Tso GJ, Yuen K, Martins S, Tu SW, Ashcraft M, Heidenreich P, Hoffman BB, Goldstein MK.

AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:240-9. eCollection 2016.

2.

Using a Clinical Knowledge Base to Assess Comorbidity Interrelatedness Among Patients with Multiple Chronic Conditions.

Zulman DM, Martins SB, Liu Y, Tu SW, Hoffman BB, Asch SM, Goldstein MK.

AMIA Annu Symp Proc. 2015 Nov 5;2015:1381-9. eCollection 2015.

3.

Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness.

Zulman DM, Asch SM, Martins SB, Kerr EA, Hoffman BB, Goldstein MK.

J Gen Intern Med. 2014 Mar;29(3):529-37. doi: 10.1007/s11606-013-2616-9. Epub 2013 Oct 1. Review.

4.

Post-fielding Surveillance of a Guideline-based Decision Support System.

Chan AS, Martins SB, Coleman RW, Bosworth HB, Oddone EZ, Shlipak MG, Tu SW, Musen MA, Hoffman BB, Goldstein MK.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

5.

Increased vascular alpha1-adrenergic sensitivity in patients with renal failure: receiving recombinant erythropoeitin.

Abiose AK, Aronow WS, Moreno H Jr, Nair CK, Blaschke TF, Hoffman BB.

Am J Ther. 2007 Sep-Oct;14(5):427-34.

PMID:
17890929
6.

Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control.

Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, Goldstein MK, Hoffman BB, Powers B, Oddone EZ.

Am Heart J. 2007 Jun;153(6):918-24.

PMID:
17540191
7.

Offline testing of the ATHENA Hypertension decision support system knowledge base to improve the accuracy of recommendations.

Martins SB, Lai S, Tu S, Shankar R, Hastings SN, Hoffman BB, Dipilla N, Goldstein MK.

AMIA Annu Symp Proc. 2006:539-43.

8.

Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care.

Lin ND, Martins SB, Chan AS, Coleman RW, Bosworth HB, Oddone EZ, Shankar RD, Musen MA, Hoffman BB, Goldstein MK.

AMIA Annu Symp Proc. 2006:494-8.

9.

Leveraging point-of-care clinician feedback to study barriers to guideline adherence.

Chan AS, Shankar RD, Coleman RW, Matins SB, Hoffman BB, Goldstein MK.

AMIA Annu Symp Proc. 2005:915.

10.
11.

Clinician awareness of adherence to hypertension guidelines.

Steinman MA, Fischer MA, Shlipak MG, Bosworth HB, Oddone EZ, Hoffman BB, Goldstein MK.

Am J Med. 2004 Nov 15;117(10):747-54.

PMID:
15541324
12.

Evaluating provider adherence in a trial of a guideline-based decision support system for hypertension.

Chan AS, Coleman RW, Martins SB, Advani A, Musen MA, Bosworth HB, Oddone EZ, Shlipak MG, Hoffman BB, Goldstein MK.

Stud Health Technol Inform. 2004;107(Pt 1):125-9.

PMID:
15360788
13.

Translating research into practice: organizational issues in implementing automated decision support for hypertension in three medical centers.

Goldstein MK, Coleman RW, Tu SW, Shankar RD, O'Connor MJ, Musen MA, Martins SB, Lavori PW, Shlipak MG, Oddone E, Advani AA, Gholami P, Hoffman BB.

J Am Med Inform Assoc. 2004 Sep-Oct;11(5):368-76. Epub 2004 Jun 7.

14.

Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose.

Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, Kopp JB, Ziyadeh FN.

Kidney Int. 2004 Apr;65(4):1191-204.

15.

Activation of alpha2 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala.

Davies MF, Tsui J, Flannery JA, Li X, DeLorey TM, Hoffman BB.

Neuropsychopharmacology. 2004 Feb;29(2):229-39.

16.

Augmentation of the noradrenergic system in alpha-2 adrenergic receptor deficient mice: anatomical changes associated with enhanced fear memory.

Davies MF, Tsui JY, Flannery JA, Li X, DeLorey TM, Hoffman BB.

Brain Res. 2003 Oct 3;986(1-2):157-65.

PMID:
12965240
17.
18.

Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.

Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB.

J Pharmacol Exp Ther. 2002 Nov;303(2):563-73.

19.

Patient safety in guideline-based decision support for hypertension management: ATHENA DSS.

Goldstein MK, Hoffman BB, Coleman RW, Tu SW, Shankar RD, O'Connor M, Martins S, Martins S, Advani A, Musen MA.

Proc AMIA Symp. 2001:214-8.

20.

Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic.

Szeto HC, Coleman RK, Gholami P, Hoffman BB, Goldstein MK.

Am J Manag Care. 2002 Jan;8(1):37-43.

21.

Analysis of drug pharmacology towards predicting drug behavior by expression profiling using high-density oligonucleotide arrays.

Hu JS, Durst M, Kerb R, Truong V, Ma JT, Khurgin E, Balaban D, Gingeras TR, Hoffman BB.

Ann N Y Acad Sci. 2000;919:9-15.

PMID:
11083092
22.
23.

Alpha(1)-adrenoceptors (alpha(1)-AR) and vascular smooth muscle cell growth.

Hoffman BB, Hu ZW.

Prostate Suppl. 2000;9:29-33. Review.

PMID:
11056500
24.

Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves.

MacRae Dell K, Hoffman BB, Leonard MB, Ziyadeh FN, Schulman SL.

Urology. 2000 Aug 1;56(2):311-4.

PMID:
10925100
25.

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.

26.

Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney.

Isono M, Mogyorósi A, Han DC, Hoffman BB, Ziyadeh FN.

Am J Physiol Renal Physiol. 2000 May;278(5):F830-8.

27.

Nicotine impairs endothelium-dependent dilatation in human veins in vivo.

Chalon S, Moreno H Jr, Benowitz NL, Hoffman BB, Blaschke TF.

Clin Pharmacol Ther. 2000 Apr;67(4):391-7.

PMID:
10801248
28.

Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.

Han DC, Hoffman BB, Hong SW, Guo J, Ziyadeh FN.

Am J Physiol Renal Physiol. 2000 Apr;278(4):F628-34.

29.

Nuclear run-on assays for measurement of adrenergic receptor transcription rate.

Hu ZW, Hoffman BB.

Methods Mol Biol. 2000;126:169-80. Review. No abstract available.

PMID:
10685409
30.

Vascular reactivity in obstructive sleep apnea syndrome.

Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Moreno H, Hoffman BB, Blaschke TF.

Am J Respir Crit Care Med. 2000 Jan;161(1):187-91.

PMID:
10619819
31.

Heparin-induced vasodilation in human hand veins.

Tangphao O, Chalon S, Moreno HJ Jr, Abiose AK, Blaschke TF, Hoffman BB.

Clin Pharmacol Ther. 1999 Sep;66(3):232-8.

PMID:
10511058
32.
34.

L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study.

Tangphao O, Chalon S, Coulston AM, Moreno H Jr, Chan JR, Cooke JP, Hoffman BB, Blaschke TF.

Vasc Med. 1999;4(1):27-32.

PMID:
10355867
35.

alpha1-adrenergic receptor activation of c-fos expression in transfected rat-1 fibroblasts: role of Ca2+.

Chen J, Lin R, Hu ZW, Hoffman BB.

J Pharmacol Exp Ther. 1999 Jun;289(3):1376-84.

36.

Pharmacokinetics of intravenous and oral L-arginine in normal volunteers.

Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TF.

Br J Clin Pharmacol. 1999 Mar;47(3):261-6.

37.

Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.

Chalon S, Moreno H Jr, Hoffman BB, Blaschke TF.

Clin Pharmacol Ther. 1999 Mar;65(3):295-303.

PMID:
10096262
38.

Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins.

Chalon S, Tejura B, Moreno H Jr, Urae A, Blaschke TF, Hoffman BB.

Br J Clin Pharmacol. 1999 Jan;47(1):91-8.

39.

Inhibition of angiotensin-converting enzyme in human hand veins.

Chalon S, Bedarida GV, Moreno H Jr, Tejura B, Urae A, Hoffman BB, Blaschke TF.

Clin Pharmacol Ther. 1999 Jan;65(1):58-65.

PMID:
9951431
40.

Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia.

Tangphao O, Chalon S, Moreno H Jr, Hoffman BB, Blaschke TF.

Clin Sci (Lond). 1999 Feb;96(2):199-207.

PMID:
9918901
42.
43.
44.

Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation.

Moreno H Jr, Chalon S, Urae A, Tangphao O, Abiose AK, Hoffman BB, Blaschke TF.

Am J Physiol. 1998 Sep;275(3 Pt 2):H1040-5.

PMID:
9724311
45.
46.

Potential role of TGF-beta in diabetic nephropathy.

Hoffman BB, Sharma K, Ziyadeh FN.

Miner Electrolyte Metab. 1998;24(2-3):190-6. Review.

PMID:
9525704
47.

Heat shock activates c-Src tyrosine kinases and phosphatidylinositol 3-kinase in NIH3T3 fibroblasts.

Lin RZ, Hu ZW, Chin JH, Hoffman BB.

J Biol Chem. 1997 Dec 5;272(49):31196-202.

48.

Chloroquine-induced venodilation in human hand veins.

Abiose AK, Grossmann M, Tangphao O, Hoffman BB, Blaschke TF.

Clin Pharmacol Ther. 1997 Jun;61(6):677-83.

PMID:
9209251
49.

Morphine-induced venodilation in humans.

Grossmann M, Abiose A, Tangphao O, Blaschke TF, Hoffman BB.

Clin Pharmacol Ther. 1996 Nov;60(5):554-60.

PMID:
8941028

Supplemental Content

Loading ...
Support Center